Last updated on October 2018

Mayo AVC Registry and Biobank


Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Familial Dilated Cardiomyopathy | Sudden Cardiac Death | Ventricular tachycardia | Myocarditis | Arrhythmia | Cardiac Sarcoidosis | Inflammatory Cardiomyopathy | Sarcoidosis | Arrhythmogenic Ventricular Cardiomyopathy | Cardiovascular Disease | Cardiomyopathy | Right Ventricular Outflow Tract Ventricular Tachycardia | Heart disease | Cardiovascular Abnormalities | Arrhythmogenic Right Ventricular Dysplasia
  • Age: - 100 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Patients with a clinical diagnosis of Arrhythmogenic Ventricular Cardiomyopathy (AVC) or suspected AVC by 2010 Task Force Criteria
  • Patient with arrhythmogenic cardiomyopathy
  • Patients with left dominant arrhythmogenic left ventricular cardiomyopathy
  • Patients with familial dilated cardiomyopathy with a propensity for arrhythmia and/or evidence of cutaneous involvement, that is suggestive of AVC phenotype
  • Patients with phenocopies which may represent early AVC (myocarditis, sarcoidosis, inflammatory cardiomyopathies, outflow tract tachycardias and Brugada pattern)
  • Family members of probands with AVC
  • Patients who have a known pathogenic variant for AVC but do not currently meet 2010 Task Force Criteria (ie genotype positive, phenotype negative)
  • Capacity to provide written consent for genetic and biobank aspects

Exclusion Criteria:

  • Hypertrophic cardiomyopathy
  • Ischemic cardiomyopathy
  • Biopsy proved cardiac amyloidosis
  • Inability or unwillingness to provide a written consent form

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.